Atossa Therapeutics

-$0.12 (-4.39%) As of 7:48 PM UTC today

Why Robinhood?

You can buy or sell ATOS and other stocks, options, and ETFs commission-free!

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests.

CEO
Steven C. Quay
Employees
8
Headquarters
Seattle, Washington
Founded
2008

ATOS Key Statistics

Market Cap
299.98M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
17.91M
High Today
$2.78
Low Today
$2.48
Open Price
$2.58
Volume
7.91M
52 Week High
$5.08
52 Week Low
$0.81

ATOS Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 25, Pre-Market

You May Also Like

FLQS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure